Jeffrey Rona

Jeffrey A.
Rona is currently the Director at S&W Seed Co. since 2023.
He is also the Chief Business & Financial Officer at Ovid Therapeutics, Inc. since 2019.
Additionally, he serves as a Trustee at The Polycystic Kidney Disease Research Foundation.
In his former positions, Mr. Rona worked as the Finance Director at Agenus, Inc. He also served as the Director & Managing Director-Western Region at Danforth Advisors LLC.
Furthermore, he was the Managing Director at Rona Capital LLC.
He held the position of Vice President-Corporate Development at Anesiva, Inc. and Chief Business Officer at GlobeImmune, Inc. Mr. Rona was also a Principal at Coopers & Lybrand LLP and UBS Warburg, Inc. He served as the Vice President-Corporate Development at Corgentech, Inc. Lastly, he was the Chief Financial Officer at AlgoRx Pharmaceuticals, Inc. and the Chief Financial Officer at Great Basin Scientific, Inc. from 2014 to 2017.
Mr. Rona obtained his undergraduate degree from Case Western Reserve University in 1990.